Proteus Digital Health Stock

proteus.comHealthcare / BioTech & PharmaFounded: 2001Funding to Date: $397.36MM

Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Proteus Digital Health before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

Proteus Digital Health Stock Price

Forge Price 1
Price no longer available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Proteus Digital Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
04/15/2016 Series H $50MM $xx.xx $1.64B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
3,164,557
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
07/29/2014 Series G $172MM $xx.xx $1.2B OrbiMed and Sailing Capital
Price per Share
$xx.xx
Shares Outstanding
13,089,802
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed and Sailing Capital
05/02/2013 Series F $62.5MM $xx.xx $426.74MM Novartis Venture Fund, ON Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, and Sutter Health Master Trust
Price per Share
$xx.xx
Shares Outstanding
10,775,862
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Novartis Venture Fund, ON Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, and Sutter Health Master Trust
12/26/2009 Series E $35MM $xx.xx $315.5MM Adams Street Partners, EW Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, and The Carlyle Group
Price per Share
$xx.xx
Shares Outstanding
6,034,483
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Adams Street Partners, EW Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, and The Carlyle Group
10/15/2008 Series D $32.05MM $xx.xx $260.3MM Adams Street Partners, EW Healthcare Partners, ITOCHU Technology Ventures, Kaiser Permanente Ventures, Medtronic, and Others
Price per Share
$xx.xx
Shares Outstanding
5,828,173
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Adams Street Partners, EW Healthcare Partners, ITOCHU Technology Ventures, Kaiser Permanente Ventures, Medtronic, and Others
08/15/2008 Series C $34.02MM $xx.xx $82.6MM Adams Street Partners, Affinity Capital Management, EW Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, and The Carlyle Group
Price per Share
$xx.xx
Shares Outstanding
17,011,801
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Adams Street Partners, Affinity Capital Management, EW Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, and The Carlyle Group
06/23/2004 Series B $11.03MM $xx.xx $16.66MM Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Spring Ridge Ventures, and Others
Price per Share
$xx.xx
Shares Outstanding
12,255,556
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Spring Ridge Ventures, and Others
12/16/2003 Series A $750,000 $xx.xx $3MM Asset Management Ventures and Spring Ridge Ventures
Price per Share
$xx.xx
Shares Outstanding
1,500,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
650.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Asset Management Ventures and Spring Ridge Ventures

Proteus Digital Health stock FAQs

plusminus

Can you buy Proteus Digital Health stock?

You can no longer buy Proteus Digital Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Proteus Digital Health stock?

You can no longer buy Proteus Digital Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Proteus Digital Health stock?

You can no longer sell stock of Proteus Digital Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Proteus Digital Health stock?

You can no longer sell stock of Proteus Digital Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is Proteus Digital Health a public company?

Proteus Digital Health is now a public company.
plusminus

What is Proteus Digital Health’s stock price?

The stock price of Proteus Digital Health is not currently available.
plusminus

What is Proteus Digital Health’s stock ticker symbol?

The ticker symbol of Proteus Digital Health is not currently available.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Proteus Digital Health investors also invested in these private companies

Leadership & Board

Leadership

Andrew Thompson
Co-Founder
George Savage, M.D.
Co-Founder, Chief Medical Officer
Mark Zdeblick, Ph.D.
Co-Founder

Board

Shumeet Banerji, Ph.D.
Frank Fischer
Immanuel Thangaraj
Regina Benjamin, MD, MBA
Alan J. Levy, Ph.D.
Joseph R. Swedish
Andrew Thompson
Sir Jonathan Symonds, CBE
Robert Epstein, M.D., M.S.
Ryan Schwarz

Proteus Digital Health’s news and media highlights

3D-printed and “smart” pharmaceuticals are making medical treatments more effective. But it may take years before the new devices reach most patients, if they do at all.
NEW YORK, Feb. 6, 2019 /PRNewswire/ -- INTRODUCTION Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to ...
スタッキング可能 スツール M-22
Updated on: Nov 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.